Created Date:
19 July 2021

Carey Olsen advises G Medical on Nasdaq listing

Carey Olsen's corporate team in Singapore has advised on the initial public offering (IPO) of G Medical Innovation Holdings Ltd. (Nasdaq: GMVD) on the Nasdaq Capital Market.

G Medical is a remote diagnostics and monitoring technology company which specialises in providing clinical-grade solutions for consumers, medical professionals and healthcare institutions.

For Carey Olsen's Singapore team it represents the second significant listing it has advised G Medical on following its groundbreaking IPO on the Australian Securities Exchange (ASX) in 2017, which at the time was the first ever Cayman Islands company to list its shares, rather than depositary interests, on the ASX.

In connection with G Medical's Nasdaq listing, Carey Olsen worked alongside US counsel Sullivan & Worcester LLP and advised the company on all Cayman Islands regulatory and legal aspects of G Medical's IPO and admission to listing. The Carey Olsen team comprised partner Anthony McKenzie, senior associate Susan McKinstray and associate Maggie Yan.

Anthony said: "We were delighted to assist G Medical on its Nasdaq IPO having previously assisted the company on its notable and innovative ASX listing in 2017. This latest transaction is another example of the Cayman Islands being seen as a jurisdiction of choice for IPOs on global stock exchanges thanks to its advanced, flexible and business-friendly laws together with a balanced regulatory regime and sophisticated professional infrastructure."

For further insight on offshore listing vehicles, including those from the Cayman Islands, please refer to our recent articles: